Testimony Before FDA Endocrinologic and Metabolic Drugs Advisory Committee Meeting on Cardiovascular Risk Assessment of Obesity

View as PDF

A dangerously low approval standard for diet drugs has created a history of recalls, injuries, and needless deaths.